Whole Exome Sequencing
As a cutting-edge method in the realm of genomics, Whole Exome Sequencing (WES) is employed to specifically sequence the coding sectors of a genome, otherwise referred to as 'exomes'. Despite only constituting about 1-2% of the complete genome, exomes are significant as they contain approximately 85% of recognized disease-associated variants. This makes WES an economical alternative for the detection of potential disease-inducing genetic variants, especially in comparison to whole genome sequencing (WGS).
WES proves to be greatly beneficial in clinical and research contexts, particularly in the diagnosis of rare genetic diseases, cancer research, and precision medicine. In this regard, as a groundbreaking technology, WES facilitates the efficient and effective determination of genes associated with diseases, hence making a significant contribution to genomic medicine.
If you are interested in our products, please don't hesitate to reach out to us.